Activities of clarithromycin, sulfisoxazole, and rifabutin against Mycobacterium avium complex multiplication within human macrophages - Wikidata - awgldk - TriplyDB

Activities of clarithromycin, sulfisoxazole, and rifabutin against Mycobacterium avium complex multiplication within human macrophages

Activities of clarithromycin, sulfisoxazole, and rifabutin against Mycobacterium avium complex multiplication within human macrophages

http://www.wikidata.org/entity/Q28330701

about

sameAs

Activities of sparfloxacin, azithromycin, temafloxacin, and rifapentine compared with that of clarithromycin against multiplication of Mycobacterium avium complex within human macrophages Extracellular and intracellular activities of clarithromycin used alone and in association with ethambutol and rifampin against Mycobacterium avium complex Activities of WIN-57273, minocycline, clarithromycin, and 14-hydroxy-clarithromycin against Mycobacterium avium complex in human macrophages Activity of clarithromycin against Mycobacterium avium complex infection in beige mice Clarithromycin, dapsone, and a combination of both used to treat or prevent disseminated Mycobacterium avium infection in beige mice Activities of rifabutin, clarithromycin, and ethambutol against two virulent strains of Mycobacterium avium in a mouse model A bone marrow-derived murine macrophage model for evaluating efficacy of antimycobacterial drugs under relevant physiological conditions Mycobacterium avium strains resistant to clarithromycin and azithromycin Comparative antimycobacterial activities of ofloxacin, ciprofloxacin and grepafloxacin MICs and MBCs of clarithromycin against Mycobacterium avium within human macrophages In vitro activities of rifabutin, azithromycin, ciprofloxacin, clarithromycin, clofazimine, ethambutol, and amikacin in combinations of two, three, and four drugs against Mycobacterium avium In vitro activity of BAY 12-8039, a new fluoroquinolone Sparfloxacin, ethambutol, and cortisol receptor inhibitor RU-40 555 treatment for disseminated Mycobacterium avium complex infection of normal C57BL/6 mice.Medicaid policies for HIV-related prescription drugs.Use of normal C57BL/6 mice with established Mycobacterium avium infections as an alternative model for evaluation of antibiotic activity.Postantibiotic effect of clarithromycin alone and combined with ethambutol against Mycobacterium avium complex The phagosomal environment protects virulent Mycobacterium avium from killing and destruction by clarithromycin.Efficacy of granulocyte colony-stimulating factor and RU-40555 in combination with clarithromycin against Mycobacterium avium complex infection in C57BL/6 mice.Inhibition of intracellular growth of Mycobacterium avium by one pulsed exposure of infected macrophages to clarithromycin.Clarithromycin, minocycline, and rifabutin treatments before and after infection of C57BL/6 mice with Mycobacterium avium Pharmacokinetics, toxicity, and efficacy of liposomal capreomycin in disseminated Mycobacterium avium beige mouse model Clarithromycin-ciprofloxacin-amikacin for therapy of Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS.In vitro susceptibilities of spotted fever group rickettsiae and Coxiella burnetti to clarithromycin The Mycobacterium avium complex Activity of clarithromycin compared with those of other drugs against Mycobacterium paratuberculosis and further enhancement of its extracellular and intracellular activities by ethambutol In vitro and ex vivo activities of antimicrobial agents used in combination with clarithromycin, with or without amikacin, against Mycobacterium avium.Absolute bioavailability of clarithromycin after oral administration in humans.Comparison of the intracellular activities of clarithromycin and erythromycin against Mycobacterium avium complex strains in J774 cells and in alveolar macrophages from human immunodeficiency virus type 1-infected individuals.Pharmacokinetics of clarithromycin, a new macrolide, after single ascending oral doses.Efficacies of liposome-encapsulated clarithromycin and ofloxacin against Mycobacterium avium-M. intracellulare complex in human macrophages.New macrolide antibiotics: usefulness in infections caused by mycobacteria other than Mycobacterium tuberculosis.Medicaid policies for HIV-related drug therapies: perspectives of the state affiliates of the American Pharmaceutical Association.Pharmacokinetics of clarithromycin extended-release (ER) tablets in patients with AIDS.

P2860

Q28321761-733E7550-D5A9-4161-82DC-E933196435F3 Q28326449-23B74E43-0AE3-411B-A51D-B136DCE4AFF6 Q28326992-E5C8E22C-B495-44CB-84CC-CCAB826775B4 Q28327192-5F52411D-39D1-4888-B583-AC401EC95616 Q28368056-FB896212-1392-491D-86AB-F8BCB078C426 Q28368218-18781F3A-B6C6-4BED-9A0D-24593E3BFFE7 Q28368663-AC272FEE-2916-4BDA-81A7-115D8CC33499 Q28369301-FEDD3516-1054-409D-9701-0FE8C1611C1B Q28376027-6546F537-7599-4BCC-9B28-7B02A5BE0822 Q28378654-AF05758C-D05A-4361-9C4B-E0BEEF846C75 Q28379222-1CBE4334-0F0A-4A9A-9677-FA745D20521A Q28379381-C744E312-DEE9-49F4-AC15-82661348F061 Q33745057-8DA3DCA5-25E7-46E7-B7A5-5D46E8F5C6C9 Q34321740-991CFCEF-FA2E-486E-B84D-B5A81934E532 Q35112519-9DDCA1EA-9E9F-4408-B6F9-0D6B79883D1D Q35121082-1C9379C1-94F6-4FFD-9A6E-7668CB50BE30 Q35551106-8BE85684-5D3A-4AFF-8FA4-9231CADF1421 Q35811091-A42AF83F-0492-40F7-BB3A-64B73632AF31 Q35816447-A8F16196-7180-4A96-A9FF-121D200A613E Q35818014-9761128B-1610-4789-81CA-883D077D73B8 Q35822868-4E40F0FE-7ABC-4609-9DCA-45A0CFD8104B Q35885553-3B03DAEE-6B65-43EE-A27B-B4F6E3145A11 Q35904249-1CFBB13B-F0A4-482D-B98C-57553F59886E Q36640345-5D8DF63A-A44D-4F5B-B6BB-C98B467D9E91 Q36758455-6863B791-642B-4518-AE71-321B0E3F7681 Q39779350-AB083AFA-3D2E-4925-9575-2B40967B2D0F Q39869470-31375812-7EF7-4023-9BDE-765F8348E926 Q39869488-1FA466DD-00F3-4C7E-9E78-143E39D7A0B6 Q40284512-6311E34E-46FC-4D1E-B532-7AEC35B31A20 Q40285262-48003D08-11AB-4AAB-B669-4C58313ECFA2 Q40588136-58E16A86-3181-408D-B73F-D06991109C46 Q40676087-A4154144-C49B-4C1C-AF72-976990AC5C0E Q46818289-460427B2-86C4-44A1-BA38-ACEC61DCCBDF

P2860

Activities of clarithromycin, sulfisoxazole, and rifabutin against Mycobacterium avium complex multiplication within human macrophages

http://www.wikidata.org/entity/Q28330701

description

1990 nî lūn-bûn

@nan

1990 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

1990 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

1990年の論文

@ja

1990年論文

@yue

1990年論文

@zh-hant

1990年論文

@zh-hk

1990年論文

@zh-mo

1990年論文

@zh-tw

1990年论文

@wuu

name

Activities of clarithromycin, ...... ation within human macrophages

@ast

Activities of clarithromycin, ...... ation within human macrophages

@en

Activities of clarithromycin, ...... ation within human macrophages

@nl

type

label

Activities of clarithromycin, ...... ation within human macrophages

@ast

Activities of clarithromycin, ...... ation within human macrophages

@en

Activities of clarithromycin, ...... ation within human macrophages

@nl

prefLabel

Activities of clarithromycin, ...... ation within human macrophages

@ast

Activities of clarithromycin, ...... ation within human macrophages

@en

Activities of clarithromycin, ...... ation within human macrophages

@nl

P1433

Q28330701-F2B33026-25E0-471C-84DB-234EC036B06E

P1476

Q28330701-30FEF9BF-9D6D-4DB4-B9EB-271900AE528B

P2093

Q28330701-0A86E1D5-D45C-4089-8B48-0606B8AFD191

Q28330701-1D7FA68F-06CA-4306-B496-62C4FA37DC59

Q28330701-33B91A9D-3EB4-443B-905C-0BA16CECF57F

Q28330701-4B6B4BB4-2A3D-40D3-92A6-9B49FBC886C5

Q28330701-9DA9382E-8381-4AA9-9D50-5DD29DE6F0A1

Q28330701-D190EF18-F946-400D-955E-88DBA00ADF88

P2860

Q28330701-0FA42AE3-D1E4-436B-AF94-D15611218C00

Q28330701-10F9895F-810A-4242-957D-0C5EEF4968E0

Q28330701-22E110AD-9841-47B3-B60F-2536F83F4172

Q28330701-24C70F0B-6055-48F8-A702-8FF3F62AB9AC

Q28330701-3158AEE0-5E7D-42C2-92E2-0B28CA172EB9

Q28330701-34681DC6-96A0-4710-94AD-0E37FF76C690

Q28330701-5541F9FD-E02B-4599-8EF6-8BCBCE84995A

Q28330701-5F1C9010-E1D0-4A9B-B2CD-B2409397AA9E

Q28330701-72240C9E-28D7-4658-B3BF-136546C5CF63

Q28330701-738BEC5D-A019-4F3C-8DE7-2A4111EE544D

P304

Q28330701-45CF36EF-B90D-4F93-90EF-B074D0457EE5

P31

Q28330701-B923684E-305F-4A18-8B7B-9973D5CDC23D

P356

Q28330701-F21D20B9-8610-469E-8FCF-966A2E5FC31A

P407

Q28330701-F4A203FF-90AC-476D-996E-B528AA714ABA

P433

Q28330701-5466837A-CFB0-4041-8E4F-0E280469AF2C

P478

Q28330701-1616A393-301C-48A9-9D26-1947B6D4A7B3

P577

Q28330701-6F046899-1062-4563-81C5-395AFC2BA448

P5875

Q28330701-AE59D514-70C9-4D56-BEA1-18EC0A61533D

P698

Q28330701-36E2A525-9DF8-4305-B3DB-75913EBDE19E

P921

Q28330701-09B18401-9A2B-472D-87B9-D9568EB08B6F

P932

Q28330701-C1B9952E-C9A0-4A4D-9608-036DE2DC4D42

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Activities of clarithromycin, ...... ation within human macrophages

@en

P2093

A Gikas

http://www.w3.org/2001/XMLSchema#string

C Perronne

http://www.w3.org/2001/XMLSchema#string

C Truffot-Pernot

http://www.w3.org/2001/XMLSchema#string

J Grosset

http://www.w3.org/2001/XMLSchema#string

J J Pocidalo

http://www.w3.org/2001/XMLSchema#string

J L Vilde

http://www.w3.org/2001/XMLSchema#string

P2860

In vitro and in vivo activities of clarithromycin against Mycobacterium avium

Amikacin, ciprofloxacin, and imipenem treatment for disseminated Mycobacterium avium complex infection of beige mice

In vitro activities of several new macrolide antibiotics against Mycobacterium avium complex

In vivo activity of amikacin alone or in combination with clofazimine or rifabutin or both against acute experimental Mycobacterium avium complex infections in beige mice

Comparative in vitro activities of MDL 473, rifampin, and ansamycin against Mycobacterium intracellulare.

Activities of amikacin, roxithromycin, and azithromycin alone or in combination with tumor necrosis factor against Mycobacterium avium complex.

Comparison of 15 laboratory and patient-derived strains of Mycobacterium avium for ability to infect and multiply in cultured human macrophages

Mycobacterium avium complex infection.

Pharmacokinetics of rifabutin.

Therapeutic implications of inhibition versus killing of Mycobacterium avium complex by antimicrobial agents.

P304

1508-11

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.34.8.1508

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P577

1990-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

20985477

http://www.w3.org/2001/XMLSchema#string

P698

2171421

http://www.w3.org/2001/XMLSchema#string

P921

P932

171862

http://www.w3.org/2001/XMLSchema#string